More broadly, PML appears to facilitate innate immunity and inflammation by affecting expression of cytokines beyond IFNs including tumor necrosis factor (TNF) and C-C motif chemokine ligand 5 (CCL5) [37–39]. The gene discussed is CCL5; the disease is progressive multifocal leukoencephalopathy.